- Previous Close
0.0150 - Open
0.0200 - Bid 0.0150 x --
- Ask 0.0200 x --
- Day's Range
0.0200 - 0.0250 - 52 Week Range
0.0150 - 0.1150 - Volume
132,000 - Avg. Volume
31,441 - Market Cap (intraday)
1.141M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NAVCO Pharmaceuticals Inc. researches, develops, manufactures, and commercializes nanotechnology products and materials. It offers aerosol spray, hand cream and sanitizer, and colloidal silver products. The company also provides COVID PCR testing, PPE, and diagnostic PCR testing, as well as textile and food solutions. Its products are used in medical, personal care products, textile, chemical, and additive industries. The company is headquartered in Burlington, Canada.
navcopharma.com--
Full Time Employees
September 30
Fiscal Year Ends
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Recent News: NAV.V
View More
Performance Overview: NAV.V
Trailing total returns as of 2024-11-11, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NAV.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NAV.V
View MoreValuation Measures
Market Cap
1.14M
Enterprise Value
1.41M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
294.63
Enterprise Value/Revenue
24.00
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-87.59%
Return on Equity (ttm)
152.57%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
489.32k
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
11.21k
Total Debt/Equity (mrq)
3,962.72%
Levered Free Cash Flow (ttm)
-293.74k